A detailed history of Wasatch Advisors Inc transactions in Biomerica Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 953,264 shares of BMRA stock, worth $419,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
953,264
Previous 953,264 -0.0%
Holding current value
$419,436
Previous $1.19 Million 33.59%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$1.12 - $1.87 $24,314 - $40,595
-21,709 Reduced 2.23%
953,264 $1.3 Million
Q1 2023

May 12, 2023

BUY
$1.86 - $3.56 $744,000 - $1.42 Million
400,000 Added 69.57%
974,973 $1.82 Million
Q4 2022

Feb 14, 2023

BUY
$3.04 - $4.17 $360,449 - $494,432
118,569 Added 25.98%
574,973 $1.93 Million
Q3 2022

Nov 14, 2022

BUY
$2.61 - $3.78 $1.19 Million - $1.73 Million
456,404 New
456,404 $1.79 Million

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $5.91M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.